Skip to content

Risk Stratification and Size Thresholds

TL;DR — The 5.5 cm ascending threshold descends directly from the Yale natural-history work of the 1990s: median size at rupture/dissection was ~6 cm for the ascending aorta, complication risk "hinged" upward sharply at 6 cm, so surgery was set a half-centimeter earlier. Then IRAD showed that 59% of type A dissections occur below 5.5 cm (the "aortic size paradox") — resolved, at least partly, by the denominator: small aortas are enormously more common, and per-person relative risk still rises ~6,000-fold once the aorta reaches 4.5 cm. Because absolute diameter ignores body size, indexed measures (ASI, AHI, cross-sectional area/height) now stratify risk into ~4%→~20%/yr bands and have entered the 2022 guideline (2a–2b). Women dissect and die more than their share at smaller absolute diameters; genotype shifts thresholds by up to a centimeter; aortic length is an emerging second dimension. What remains unsolved is the actual clinical question: predicting which individual 4.8 cm aorta will dissect this year — no tool for that has been prospectively validated, and the first RCT of early surgery vs surveillance at 5.0–5.4 cm (TITAN:SvS) is still enrolling.

The hinge point: how the thresholds were born (Yale, 1997–2002)

  • Coady 1997 (230 patients, 714 serial imaging studies): median aortic size at rupture or dissection was 6.0 cm for ascending and 7.2 cm for descending aneurysms. Multivariable analysis: exceeding 6.0 cm raised the probability of rupture/dissection by 32.1 percentage points for the ascending aorta (p=0.005); >7.0 cm by 43 points for the descending. Because intervening at the median complication size would let half of patients dissect first, the authors recommended elective resection at 5.5 cm ascending / 6.5 cm descending (Coady 1997, PMID 9081092).
  • Coady 1999 (370 patients, 1,063 studies) refined the same conclusion: mean growth 0.10 cm/yr; ≥6.0 cm raised ascending complication probability by 25.2 percentage points; recommendations unchanged (Coady 1999, PMID 10391339).
  • Davies 2002 converted cumulative into yearly risk (721 patients, 3,115 studies): for aneurysms >6 cm, rupture 3.7%/yr, rupture or dissection 6.9%/yr, death 11.8%/yr, and the combined endpoint ~15.6%/yr; odds of rupture rose 27-fold above 6.0 cm; elective repair restored near-normal life expectancy (Davies 2002, PMID 11834007).

The logic — operate one growth-increment (~0.5 cm ≈ several years at 0.1 cm/yr) before the hinge, provided elective mortality is low — has anchored every guideline since (guidelines). Deep note: literature/notes/coady-1997-hinge-points.md.

The aortic size paradox (and its partial resolution)

Pape 2007 (IRAD): among 591 type A dissections, mean maximum aortic diameter at presentation was 5.3 cm; 59% dissected at <5.5 cm and 40% at <5.0 cm. Hypertension, radiating pain, and older age predicted dissection at smaller size; Marfan patients dissected at larger diameters (OR 14.3). Conclusion: "methods other than size measurement of the ascending aorta are needed" (Pape 2007, PMID 17709637).

Taken alone this seemed to demolish the 5.5 cm criterion. Paruchuri 2015 supplied the missing denominator using a 3,573-subject community MRI sample (MESA): 79.2% of the population has an ascending aorta <3.5 cm, 2.6% measures 4.0–4.4 cm, and only 0.22% is ≥4.5 cm. Dividing observed dissections by the population at risk at each size: relative risk ≈2.5 at 3.5–3.9 cm, ≈4.9 at 4.0–4.4 cm (89-fold vs the ≤3.4 cm reference in the guideline's citation of these data), and ~6,305× at ≥4.5 cm vs <3.5 cm. Most dissections arise from small aortas because almost all aortas are small — per-aorta risk still climbs explosively with size (Paruchuri 2015, PMID 25997607; Isselbacher 2022, PMID 36322642).

Both facts stand: population-level prevention cannot rely on diameter alone (most dissections occur below the surgical threshold), and diameter remains the strongest single per-patient predictor. This tension drives everything below.

Indexed size: correcting diameter for the patient

A 5.0 cm aorta means different things in a 1.55 m woman and a 2.0 m man. Three ratios have accumulated outcome data:

Index Definition Risk bands (yearly complication rates) Source
Aortic size index (ASI) diameter (cm) / BSA (m²) <2.75 low (~4%/yr); 2.75–4.24 moderate (~8%/yr); >4.25 high (~20%/yr) 410 Yale patients with BSA data (Davies 2006, PMID 16368358)
Aortic height index (AHI) diameter (cm) / height (m) ≤2.43 → ~4%/yr; 2.44–3.17 → ~7%; 3.21–4.06 → ~12%; ≥4.1 → ~18%/yr 780 Yale patients; AHI predicted at least as well as ASI — weight adds little, height suffices (Zafar 2018, PMID 29395211)
Cross-sectional area / height π(d/2)² (cm²) / height (m) ≥10 cm²/m marks elevated risk; proposed for Marfan (2002), then BAV (2003) Cleveland Clinic (Svensson 2002, PMID 11828302; Svensson 2003, PMID 14502185)

Guideline uptake (2022 ACC/AHA): area/height ≥10 cm²/m is a 2a trigger in Marfan and BAV and (at experienced centers) in sporadic aneurysm; ASI ≥3.08 cm/m² or AHI ≥3.21 cm/m is a 2b trigger for sporadic root/ascending aneurysm; Turner syndrome uses ASI (≥2.5 cm/m² + risk factors → 2a) (Isselbacher 2022, PMID 36322642). Deep note: literature/notes/davies-2006-aortic-size-index.md.

Sex differences

  • Women are a minority of acute dissections (32.1% in IRAD) but present older, later, and sicker; in-hospital mortality is higher than men's (adjusted OR 1.4), and type A surgical mortality was 32% vs 22% despite similar delay and technique (Nienaber 2004, PMID 15197151).
  • Unoperated TAA grows about twice as fast in women (0.96 vs 0.45 mm/yr), with aortic stiffness associated with growth only in women (Boczar 2019, PMID 30571545).
  • Population data (Nova Scotia, 2005–2015): women were 23% of elective TAA repairs and 22% of type A repairs but 45% of aorta-related deaths; repair incidence rose over time in men only (Cote 2022, PMID 36562011).
  • In TGFBR2-mutation carriers, type A dissection occurred at root diameters ≤45 mm in 6 women with marked systemic features and low BSA (Jondeau 2016, PMID 27879313).
  • The 2022 guideline concedes that indexed ratios "may be particularly useful for female patients, but more studies are required to further evaluate surgical thresholds in women" — absolute-diameter thresholds remain formally sex-neutral (Isselbacher 2022, PMID 36322642).

Because women are shorter on average, height-indexed criteria (AHI, area/height) partially absorb the sex gap without a separate female threshold; whether that fully captures female excess risk is open.

Aortic length: the neglected dimension

The aneurysmal ascending aorta elongates as well as widens. In 522 Yale patients, ascending length ≥13 cm carried ~5× the yearly adverse-event rate of <9 cm, with probability "hinge points" at 11.5–12.0 and 12.5–13.0 cm; mean elongation was 0.18 cm/yr. Crucially, dissection itself inflates diameter ~18% but length only 2.7% — so length read at presentation is a less contaminated marker of the pre-dissection aorta. A combined diameter+length height index improved discrimination (AUC 0.810), and the authors proposed ~11 cm as a potential intervention criterion (Wu 2019, PMID 31526537). Length remains outside formal guideline criteria; the 2022 document lists it (with ASI/AHI, area/height, stiffness, wall stress) among predictors that are "retrospectively promising, but none has been prospectively validated" (Isselbacher 2022, PMID 36322642).

Growth rate as an independent trigger

Documented expansion signals a biologically active wall independent of current size: 2022 ACC/AHA makes growth ≥0.3 cm/yr in 2 consecutive years or ≥0.5 cm in 1 year a Class 1 (C-LD) surgical indication below 5.5 cm — with the caveat that growth must be confirmed on comparable tomographic studies because typical annual growth (~0.1 cm) is smaller than measurement error (Isselbacher 2022, PMID 36322642; Davies 2002, PMID 11834007; see imaging).

Genotype-adjusted thresholds

Family history and genotype move the threshold more than any imaging ratio:

  • TGFBR1/TGFBR2 (Loeys-Dietz spectrum) — Montalcino Aortic Consortium, 441 patients: 23% aortic dissection, similar overall survival by gene, but TGFBR1 risk was male-skewed while TGFBR2 women with low BSA and severe systemic features dissected at root ≤45 mm; authors proposed preventive surgery at 45 mm, lowered toward 40 mm in that high-risk female subgroup (Jondeau 2016, PMID 27879313).
  • 2022 ACC/AHA: Loeys-Dietz gets gene- and feature-modulated thresholds (e.g., replacement of arch/descending/abdominal segments may be considered at ≥4.5 cm for pathogenic variants in the LDS genes, 2b C-EO); nonsyndromic heritable TAD with no identified variant: repair at ≥5.0 cm (or ≥4.5 cm when a relative dissected <5.0 cm, when high-risk features exist, or during cardiac surgery for another indication, 2a C-LD). The guideline tabulates per-gene thresholds for the HTAD genes; the per-gene values are in the source document's tables (Isselbacher 2022, PMID 36322642; see genetics of TAA, syndromic aortopathies).
  • Marfan: 5.0 cm (1 B-NR), 4.5 cm with dissection-risk features (2a) (guidelines; Isselbacher 2022, PMID 36322642).

Risk calculators and the individualized-prediction gap

Despite two decades of refinements, decision-making still reduces to threshold crossing. The 2022 guideline's own summary: ASI, AHI, area/height, length, stiffness, and peak wall stress are all "retrospectively promising, but none has been prospectively validated" (Isselbacher 2022, PMID 36322642). Two developments to watch:

  • TITAN:SvS (NCT03536312; recruiting, target 610, 28 sites, primary completion 2035): the first randomized comparison of early elective surgery vs surveillance for ascending aneurysms of 5.0–5.4 cm — direct test of whether the "experienced-center 5.0 cm" practice (2a in 2022) improves outcomes.
  • Biomechanical and biomarker-based individual prediction (wall stress, 4D-flow, circulating markers) — see hemodynamics and biomechanics and biomarkers; none is decision-grade yet (Isselbacher 2022, PMID 36322642).

Open questions

  • What is the dissection rate per year at 4.5–5.4 cm under modern medical therapy — precisely the range where the paradox lives and where TITAN:SvS (NCT03536312) randomizes? Existing yearly-rate bands derive from referral cohorts (Davies 2002, PMID 11834007) and relative-risk estimates lack absolute denominators (Paruchuri 2015, PMID 25997607).
  • Should women have explicitly lower absolute thresholds, or do height-indexed criteria suffice? Female excess mortality and smaller dissection diameters are documented (Nienaber 2004, PMID 15197151; Jondeau 2016, PMID 27879313), but no sex-specific threshold has been prospectively tested (Isselbacher 2022, PMID 36322642).
  • Can ascending length (or diameter+length AHI) be validated prospectively as an intervention criterion (proposed 11 cm hinge; Wu 2019, PMID 31526537)?
  • Why does the aorta of Marfan patients dissect at larger diameters in IRAD (OR 14.3; Pape 2007, PMID 17709637) while genotype cohorts dissect small (Jondeau 2016, PMID 27879313) — surveillance bias, ascertainment, or biology?
  • Growth-rate criteria assume measurable growth, but annual growth is below single-scan error (Davies 2002, PMID 11834007; Quint 2013, PMID 22864960) — what imaging pipeline makes the 0.3 cm/yr criterion operationally reliable?
  • Can a multivariable calculator (size + index + length + sex + genotype + BP + family history) outperform 5.5 cm? None validated as of the 2022 guideline (Isselbacher 2022, PMID 36322642).

References

  1. Coady MA, Rizzo JA, Hammond GL, et al. What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Thorac Cardiovasc Surg. 1997;113:476-491. PMID 9081092. doi:10.1016/S0022-5223(97)70360-X
  2. Coady MA, Rizzo JA, Hammond GL, et al. Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications. Ann Thorac Surg. 1999;67:1922-1926. PMID 10391339. doi:10.1016/s0003-4975(99)00431-2
  3. Davies RR, Goldstein LJ, Coady MA, et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg. 2002;73:17-27. PMID 11834007. doi:10.1016/s0003-4975(01)03236-2
  4. Pape LA, Tsai TT, Isselbacher EM, et al. Aortic diameter ≥5.5 cm is not a good predictor of type A aortic dissection: observations from IRAD. Circulation. 2007;116:1120-1127. PMID 17709637. doi:10.1161/CIRCULATIONAHA.107.702720
  5. Paruchuri V, Salhab KF, Kuzmik G, et al. Aortic size distribution in the general population: explaining the size paradox in aortic dissection. Cardiology. 2015;131:265-272. PMID 25997607. doi:10.1159/000381281
  6. Davies RR, Gallo A, Coady MA, et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg. 2006;81:169-177. PMID 16368358. doi:10.1016/j.athoracsur.2005.06.026
  7. Zafar MA, Li Y, Rizzo JA, et al. Height alone, rather than body surface area, suffices for risk estimation in ascending aortic aneurysm. J Thorac Cardiovasc Surg. 2018;155:1938-1950. PMID 29395211. doi:10.1016/j.jtcvs.2017.10.140
  8. Svensson LG, Khitin L. Aortic cross-sectional area/height ratio timing of aortic surgery in asymptomatic patients with Marfan syndrome. J Thorac Cardiovasc Surg. 2002;123:360-361. PMID 11828302. doi:10.1067/mtc.2002.118497
  9. Svensson LG, Kim KH, Lytle BW, Cosgrove DM. Relationship of aortic cross-sectional area to height ratio and the risk of aortic dissection in patients with bicuspid aortic valves. J Thorac Cardiovasc Surg. 2003;126:892-893. PMID 14502185. doi:10.1016/s0022-5223(03)00608-1
  10. Nienaber CA, Fattori R, Mehta RH, et al. Gender-related differences in acute aortic dissection. Circulation. 2004;109:3014-3021. PMID 15197151. doi:10.1161/01.CIR.0000130644.78677.2C
  11. Boczar KE, Cheung K, Boodhwani M, et al. Sex differences in thoracic aortic aneurysm growth. Hypertension. 2019;73:190-196. PMID 30571545. doi:10.1161/HYPERTENSIONAHA.118.11851
  12. Cote CL, De Waard D, Kivell M, et al. Sex differences in trends in incidence of thoracic aortic aneurysm repair and aortic dissection: 2005-2015. CJC Open. 2022;4:1081-1089. PMID 36562011. doi:10.1016/j.cjco.2022.08.012
  13. Jondeau G, Ropers J, Regalado E, et al. International registry of patients carrying TGFBR1 or TGFBR2 mutations: results of the MAC (Montalcino Aortic Consortium). Circ Cardiovasc Genet. 2016;9:548-558. PMID 27879313. doi:10.1161/CIRCGENETICS.116.001485
  14. Wu J, Zafar MA, Li Y, et al. Ascending aortic length and risk of aortic adverse events: the neglected dimension. J Am Coll Cardiol. 2019;74:1883-1894. PMID 31526537. doi:10.1016/j.jacc.2019.07.078
  15. Isselbacher EM, Preventza O, Hamilton Black J, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease. Circulation. 2022;146:e334-e482. PMID 36322642. doi:10.1161/CIR.0000000000001106
  16. Quint LE, Liu PS, Booher AM, et al. Proximal thoracic aortic diameter measurements at CT: repeatability and reproducibility according to measurement method. Int J Cardiovasc Imaging. 2013;29:479-488. PMID 22864960. doi:10.1007/s10554-012-0102-9
  17. Treatment in Thoracic Aortic Aneurysm: Surgery versus Surveillance (TITAN:SvS). ClinicalTrials.gov registration NCT03536312 (recruiting; n=610 target; verified via ClinicalTrials.gov query 2026-08-27).